Cargando…
COVID-19 and Solid Organ Transplantation: Role of Anti-SARS-CoV-2 Monoclonal Antibodies
PURPOSE OF REVIEW: Solid organ transplant recipients (SOTRs) are ideal candidates for early treatment or prevention of coronavirus disease 2019 (COVID-19) using anti-SARS-CoV-2 monoclonal antibodies because of multiple underlying medical conditions, chronic immune-suppression, sub-optimal immunogeni...
Autores principales: | Dhand, Abhay, Razonable, Raymund R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760599/ https://www.ncbi.nlm.nih.gov/pubmed/35070639 http://dx.doi.org/10.1007/s40472-022-00357-2 |
Ejemplares similares
-
SARS-CoV-2 Vaccines: Safety and Immunogenicity in Solid Organ Transplant Recipients and Strategies for Improving Vaccine Responses
por: Grupper, Ayelet, et al.
Publicado: (2022) -
Antivirals for COVID-19 in Solid Organ Transplant Recipients
por: Laracy, Justin C., et al.
Publicado: (2020) -
Immunomodulatory Therapies for COVID-19 in Solid Organ Transplant Recipients
por: Fernández-Ruiz, Mario, et al.
Publicado: (2020) -
General Approach to the Clinical Care of Solid Organ Transplant Recipients with COVID-19 Infection: Management for Transplant Recipients
por: Kim, Min Young, et al.
Publicado: (2020) -
Diagnostic Testing of COVID-19 in Solid Organ Transplantation: Current Clinical Application and Future Strategies
por: Trubin, Paul A., et al.
Publicado: (2020)